SARS News and Research

RSS

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Scientists have recently studied the duration of protection provided by mRNA-based COVID-19 vaccines against symptomatic omicron infection, and associated severity and mortality.

9 Feb 2022

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Researchers looked at the efficiency of COVID-19 vaccines in preventing infection, hospitalization, and death in the general population of Sweden over the first nine months following vaccination.

9 Feb 2022

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

The scientists tested samples collected from free-living and confined deer in Iowa to see if infection and subsequent transmission of SARS-CoV-2 in deer happens in nature.

9 Feb 2022

Danish study of long COVID in teens

As an aftermath of the extended lockdowns and social distancing restrictions, Coronavirus disease 2019 (COVID-19) has impacted the quality of life of children and adolescents worldwide, not only physically due to the infection, but also mentally. A high level of anxiety and depression has been reported among pediatric patients and adolescents, many of whom were deprived of social interaction with peers during the pandemic.

9 Feb 2022

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has long been debated among scientists. However, prior research found early genetic material of a unique SARS-CoV-2 variant from the soil on King George Island, Antarctica between 24 December 2018 and 13th January 2019.

9 Feb 2022

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

A study by researchers from the United Kingdom finds no difference in the protection offered by mRNA vaccine boosters against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) when comparing those that have received BioNTech/Pfizer vaccine as a primary course to those that have received Oxford/AstraZeneca.

8 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

A team of scientists led by Cold Spring Harbor Laboratory (CSHL) have discovered that disulfiram, an FDA-approved drug, prevents the immune system from producing toxic webs known as neutrophil extracellular traps (NETs).

8 Feb 2022

The B and T cell responses to SARS-CoV-2

Researchers assess the correlation between humoral and cell-mediated responses to SARS-CoV-2 in symptomatic and asymptomatic individuals.

8 Feb 2022

Swedish study shows fully vaccinated are protected against severe COVID-19

Researchers evaluate the risk of severe Omicron infections in several risk categories defined by sex, age, comorbidities, and vaccination status.

8 Feb 2022

Experts agree on research definition of Long COVID in children and young people

The first research definition of what is meant by post acute COVID-19, dubbed 'Long COVID' in children and young people has been formally agreed, reveals a landmark study accepted for publication in the Archives of Disease in Childhood.

8 Feb 2022

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

A new study examined the clinical manifestations of SARS-CoV-2 infections, disease severity, and related hospitalization in infants in Canada.

8 Feb 2022

Impact of SARS-CoV-2 Omicron and Delta variants on serious hospital events

In a new study, a team of researchers assessed the differences in risk of hospitalization in adults after infection with SARS-CoV-2 Omicron and Delta variants.

8 Feb 2022

Exploring the high incidence of croup in children during the SARS-CoV-2 Omicron wave

In a new study, researchers observed that the incidence of pediatric croup was higher during the latest surge of COVID-19 infections driven by the SARS-CoV-2 Omicron variant.

8 Feb 2022

Comparison of school protocols under the high incidence conditions due to the Omicron variant

The current study discusses the proactive vs. reactive school protocols relative to the peak demands for resources, break in infection, and the number of days of school lost.

8 Feb 2022

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

The current study describes the results of examining a patient database to understand just how Omicron affected the clinical outcome.

8 Feb 2022

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

The new study uses PCR data on 17 different pathogens, collected from clinical samples as part of the Seattle Flu Study, a community-based surveillance study of respiratory viral infections.

8 Feb 2022

SARS-CoV-2 in the exhaled breath of COVID-19 patients might be mainly transmitted via respiratory droplets

Researchers found evidence that SARS-CoV-2 particles are released directly into the air through the breathing of COVID-19 patients resulting in respiratory transmission of the virus.

8 Feb 2022

Evidence from a major US metropolitan area on home testing and risk factors for acquisition of SARS-CoV-2 infection

A new study analyzed the risk factors for acquiring COVID-19 in a large, prospective cohort of adult residents in the Boston metropolitan area.

8 Feb 2022

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

Researchers conducted a retrospective cohort analysis by reviewing medical records of pregnant women to examine the impact of SARS-CoV-2 maternal infection on maternal and perinatal outcomes.

8 Feb 2022

SARS News and Research

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

Danish study of long COVID in teens

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

The B and T cell responses to SARS-CoV-2

Swedish study shows fully vaccinated are protected against severe COVID-19

Experts agree on research definition of Long COVID in children and young people

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Impact of SARS-CoV-2 Omicron and Delta variants on serious hospital events

Exploring the high incidence of croup in children during the SARS-CoV-2 Omicron wave

Comparison of school protocols under the high incidence conditions due to the Omicron variant

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

SARS-CoV-2 in the exhaled breath of COVID-19 patients might be mainly transmitted via respiratory droplets

Evidence from a major US metropolitan area on home testing and risk factors for acquisition of SARS-CoV-2 infection

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News